Team:SDU-Denmark/safety-b

From 2010.igem.org

(Difference between revisions)
m (References)
(Risk-assessment for Individual Parts)
Line 28: Line 28:
===Methode===
===Methode===
-
<p style="text-align: justify;">We have used our risk-assessment paper to describe the safety of each of our contributed parts. The genes were [http://blast.ncbi.nlm.nih.gov/Blast.cgi BLASTed] to find their function and known homologs. This function was then reasearched (mainly via [http://www.ncbi.nlm.nih.gov/PubMed PubMed]), described and considered according to the questions asked in the risk-assessment paper.</p>
+
<p style="text-align: justify;">We have used our [http://2010.igem.org/Team:SDU-Denmark/safety-d#Procedure risk-assessment guidelines] to describe the safety of each of our contributed parts. The genes were [http://blast.ncbi.nlm.nih.gov/Blast.cgi BLASTed] to find their function and known homologs. This function was then reasearched (mainly via [http://www.ncbi.nlm.nih.gov/PubMed PubMed]), described and considered according to the questions asked in the risk-assessment paper.</p>
===[http://partsregistry.org/wiki/index.php?title=Part:BBa_K343001 Monooxygenase (Part K343001)]===
===[http://partsregistry.org/wiki/index.php?title=Part:BBa_K343001 Monooxygenase (Part K343001)]===

Revision as of 11:42, 26 October 2010